Simplex Trading’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Simplex Trading’s Portfolio ARDS Stock Details ARDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,800	Closed	-$3K	–	10342
2023 Q1	$3K	Buy	+10,800	New	+$7.84K	﹤0.01%	8392
2022 Q1	–	Sell	-1,600	Closed	-$3K	–	11737
2021 Q4	$3K	Buy	+1,600	New	+$4.55K	﹤0.01%	9916

Other funds holding ARDS

Wealth Architects Mountain View, California $1.12B AUM 24.94% 1-Year Est. Return

Simplex Trading's ARDS Position: Q3 2023 in Review

Simplex Trading sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q3 2023, closing a stake of 1,293 shares.

Simplex Trading first reported a position in ARDS in Q1 2022 and held it in 5 quarters. The position peaked at $14K in Q2 2022. 1 fund tracked by Wall St. Rank holds ARDS as of Q3 2023.

Simplex Trading reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Simplex Trading sold 1,293 Aridis Pharmaceuticals Inc. Common Stock shares in Q3 2023.
Simplex Trading first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Simplex Trading's Aridis Pharmaceuticals Inc. Common Stock position peaked at $14K in Q2 2022.
1 fund tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.